Symeres acquires Woburn’s Organix, Adds Strategic Foothold in US
- Posted by ISPE Boston
- On April 28, 2022
Leading European drug discovery CRO/CDMO Symeres is set to acquire Woburn-based Organix, a provider of high-quality organic chemistry services focused on lipids. The Organix acquisition adds a high-quality presence in the US market, where Symeres generates nearly 50% of its revenues, and broadens Symeres’ drug discovery offering into the fast-growing lipids market, addressing mRNA therapeutics […]
Read More